Leslie Duplaquet, PhD

Leslie Duplaquet, PhD, was a research fellow in the laboratory from 2019-2025, where she worked on identifying novel therapeutic strategies for small cell lung cancer (SCLC) using CRISPR/Cas9 screens and characterizing epigenetic mechanisms underlying SCLC plasticity. During her postdoctoral training, she was awarded a Philippe Foundation fellowship supporting scientific exchanges between France and the United States. 
She is now a Research Scientist (Inserm) at the Cancer Research Center of Lille (CRCLille), France, where her research focuses on understanding and overcoming drug-resistance in small cell lung cancer.